Back to Search Start Over

Evaluating the role of ARSA in Chinese patients with Parkinson's disease.

Authors :
Pan HX
Wang YG
Zhao YW
Zeng Q
Wang Z
Fang ZH
Zhang Y
Zhou X
He RC
Xu Q
Sun QY
Tan JQ
Yan XX
Li JC
Tang BS
Guo JF
Source :
Neurobiology of aging [Neurobiol Aging] 2022 Jan; Vol. 109, pp. 269-272. Date of Electronic Publication: 2021 Aug 21.
Publication Year :
2022

Abstract

Recent studies have suggested ARSA, a gene responsible for metachromatic leukodystrophy, could be a genetic modifier of Parkinson's disease (PD) pathogenesis, acting as a molecular chaperone for α-synuclein. To elucidate the role of ARSA variants in PD, we did a comprehensive analysis of ARSA variants by performing next-generation sequencing on 477 PD families, 1440 sporadic early-onset PD patients and 1962 sporadic late-onset PD patients and 2636 controls from Chinese mainland, as well as the association between ARSA variants and cognitive function of PD patients. We identified 2 familial PD following autosomal dominant inherence carrying rare variants of ARSA, but they had limited clinical significance. We detected a total of 81 coding variants of ARSA in our subjects but none of the identified variants were associated with either susceptibility or cognitive performance of PD, while loss-of-function variants showed slightly increased burden in late-onset PD (0.25% vs. 0%, p = 0.08). Our results suggested ARSA may not play important roles in PD of Chinese population.<br /> (Copyright © 2021 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1558-1497
Volume :
109
Database :
MEDLINE
Journal :
Neurobiology of aging
Publication Type :
Academic Journal
Accession number :
34531044
Full Text :
https://doi.org/10.1016/j.neurobiolaging.2021.08.008